These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21972098)

  • 1. Mechanisms and consequences of hypertriglyceridemia and cellular lipid accumulation in chronic kidney disease and metabolic syndrome.
    Lee HS
    Histol Histopathol; 2011 Dec; 26(12):1599-610. PubMed ID: 21972098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.
    Vaziri ND
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S35-43. PubMed ID: 20797569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triglyceride-rich lipoproteins in chronic kidney disease patients undergoing maintenance haemodialysis treatment.
    Homma K; Homma Y; Yamaguchi S; Shiina Y; Wakino S; Hayashi K; Hori S; Itoh H
    Int J Clin Pract; 2012 Apr; 66(4):394-8. PubMed ID: 22420498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
    Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF
    Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function.
    Guebre-Egziabher F; Alix PM; Koppe L; Pelletier CC; Kalbacher E; Fouque D; Soulage CO
    Biochimie; 2013 Nov; 95(11):1971-9. PubMed ID: 23896376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Features of hypertriglyceridemia in chronic kidney disease(CKD)].
    Saito T
    Nihon Rinsho; 2013 Sep; 71(9):1618-22. PubMed ID: 24205724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome.
    Prieur X; Roszer T; Ricote M
    Biochim Biophys Acta; 2010 Mar; 1801(3):327-37. PubMed ID: 19796705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic heparan sulfate proteoglycans and endocytic clearance of triglyceride-rich lipoproteins.
    Foley EM; Esko JD
    Prog Mol Biol Transl Sci; 2010; 93():213-33. PubMed ID: 20807647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome and renal failure: similarities and differences.
    Kaysen GA
    Panminerva Med; 2006 Sep; 48(3):151-64. PubMed ID: 17122751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acquired hypertriglyceridemia].
    Takahashi M; Ishibashi S
    Nihon Rinsho; 2013 Sep; 71(9):1597-601. PubMed ID: 24205720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhodiola crenulata root ameliorates derangements of glucose and lipid metabolism in a rat model of the metabolic syndrome and type 2 diabetes.
    Wang J; Rong X; Li W; Yang Y; Yamahara J; Li Y
    J Ethnopharmacol; 2012 Aug; 142(3):782-8. PubMed ID: 22683493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin m reduces hypertriglyceridemia through enhanced beta-oxidation.
    Zhou Y; Abidi P; Kim A; Chen W; Huang TT; Kraemer FB; Liu J
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2198-205. PubMed ID: 17761945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hypertriglyceridemia promotes intestinal lymphatic lipid and drug transport: a positive feedback mechanism in lipid and drug absorption.
    Trevaskis NL; Charman WN; Porter CJ
    Mol Pharm; 2011 Aug; 8(4):1132-9. PubMed ID: 21604764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triglycerides and gallstone formation.
    Smelt AH
    Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some aspects of lipid metabolism in fatty liver and kidney syndrome in chicks.
    Evans AJ; Bannister DW; Whitehead CC
    Res Vet Sci; 1975 Jan; 18(1):26-31. PubMed ID: 164057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid metabolism.
    Young IS; Nicholls DP
    Curr Opin Lipidol; 2007 Dec; 18(6):689-91. PubMed ID: 17993814
    [No Abstract]   [Full Text] [Related]  

  • 17. Improvement of mTORC1-driven overproduction of apoB-containing triacylglyceride-rich lipoproteins by short-chain fatty acids, 4-phenylbutyric acid and (R)-α-lipoic acid, in human hepatocellular carcinoma cells.
    Roberts JL; He B; Erickson A; Moreau R
    Biochim Biophys Acta; 2016 Mar; 1861(3):166-76. PubMed ID: 26680362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
    Wahba IM; Mak RH
    Clin J Am Soc Nephrol; 2007 May; 2(3):550-62. PubMed ID: 17699463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolving understanding of the contribution of lipid metabolism to diabetic kidney disease.
    Stadler K; Goldberg IJ; Susztak K
    Curr Diab Rep; 2015 Jul; 15(7):40. PubMed ID: 25957525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid Accumulation and Chronic Kidney Disease.
    Gai Z; Wang T; Visentin M; Kullak-Ublick GA; Fu X; Wang Z
    Nutrients; 2019 Mar; 11(4):. PubMed ID: 30925738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.